Decentralised Clinical Trials (DCTs) are reshaping the clinical research landscape, offering a patient-centric approach that reduces barriers to participation while improving efficiency and data quality. In Australia, where vast geographic distances often hinder trial accessibility, the adoption of DCTs presents a compelling opportunity for innovation.

Randomised controlled trials (RCTs) are gold-standard clinical trials that investigate the efficacy and safety of treatments by randomly assigning participants to different treatment groups. They help minimise bias, establish causality, and evaluate treatment effectiveness by comparing outcomes between groups. However, RCTs have limitations, including challenges in accounting for all risk factors, ethical considerations, limited generalisability, and resource intensiveness. Despite these drawbacks, RCTs remain essential in advancing evidence-based medicine and improving patient care.

Randomised controlled trials (RCTs) are gold-standard clinical trials that investigate the efficacy and safety of treatments by randomly assigning participants to different treatment groups. They help minimise bias, establish causality, and evaluate treatment effectiveness by comparing outcomes between groups. However, RCTs have limitations, including challenges in accounting for all risk factors, ethical considerations, limited generalisability, and resource intensiveness. Despite these drawbacks, RCTs remain essential in advancing evidence-based medicine and improving patient care.

Clinical trials are essential for advancing medical knowledge, developing new treatments, and improving patient care. However, navigating the world of clinical trials can be complex, especially for those unfamiliar with the process. In this blog post, we'll provide a comprehensive guide to understanding the phases of clinical trials, breaking down each step to help you grasp the journey from initial research to regulatory approval.